Linde plc · LIN · FY2026 Q1 · Calendar Q2 2026
Linde Q1 2026: EPS $4.33 Beats on Americas Strength, Helium Tightness and Space Push
Linde's Q1 2026 results reinforce a dual narrative: a resilient industrial-gas core anchored by Americas strength and electronics demand, layered with emerging high-growth optionality in commercial space and helium pricing. The 30% operating margin held steady year-over-year despite European softness, and management raised the low end of FY EPS guidance, signaling confidence in backlog conversion and disciplined capital allocation. The key question for investors is whether the helium shortage tailwind and commercial-space ramp can offset persistent European weakness and U.S. health-care policy headwinds over the remainder of FY2026.
Company context
Snapshot as of publicationLinde plc functions as a global industrial gas and engineering powerhouse, extending its operations throughout North and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company's comprehensive product line features atmospheric gases like oxygen, nitrogen, argon, and various rare gases, alongside a diverse array of process gases such as carbon dioxide, helium, hydrogen, specialized electronic gases, and acetylene. Beyond gas supply, Linde is also adept at designing and constructing turnkey process plants. These engineering solutions serve both third-party customers and its own gas business facilities, covering types like olefin, natural gas, air separation, hydrogen, and synthesis gas plants. Linde's extensive client base spans numerous sectors, including healthcare, energy, general manufacturing, food and beverage carbonation, fiber-optics, steel production, aerospace, chemicals, and water treatment. Established in 1879, the company is headquartered in Woking, United Kingdom.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeFollow LIN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Linde reported Q1 2026 EPS of $4.33 versus a consensus estimate of $4.27 (a 1.4% surprise) and revenue of $8.78 billion versus an estimate of $8.60 billion (a 2.1% surprise). Sales rose 8% year-over-year and EPS grew 10%. The operating margin held at 30%. The market responded modestly on the event session with an abnormal move of +1.08% (benchmark +0.28%), though the stock subsequently drifted -2.07% over the following window on 1.35x baseline volume. Compared to Q4 2025, which posted EPS of $4.20 and a 29.5% operating margin, Q1 showed continued margin and earnings improvement. The most notable shifts quarter-over-quarter: guidance sentiment moved from maintained to raised, the bullish score increased from 70 to 75, capex outlook shifted from increasing to stable at approximately $1.3 billion annually, and management flagged a new acute helium shortage alongside a more ambitious commercial-space timeline targeting $1 billion-plus in revenue potentially earlier than 2030.
Guidance delta
Management raised the lower end of full-year EPS guidance, with the prior quarter's range standing at $17.40 to $17.90. The guidance sentiment moved from maintained in Q4 2025 to raised in Q1 2026. Management expects margin expansion despite assuming no broader economic improvement. Capex outlook shifted from increasing to stable at approximately $1.3 billion annually, split between base spend and project backlog. The company also announced a 7% dividend increase and $800 million in share repurchases.
Key takeaways
- EPS of $4.33 beat consensus by 1.4%; revenue of $8.78B beat by 2.1%, with sales up 8% YoY and EPS up 10%.
- Operating margin held at 30%, up from 29.5% in the prior quarter, despite continued European industrial weakness.
- Americas delivered the strongest volume and pricing growth; Europe remained soft; APAC was seasonal.
- Helium shifted from oversupply to an acute global shortage, providing pricing upside with 85 to 90% of customers under long-term contracts.
- Commercial space services are being positioned as a new high-growth line, targeting $1B-plus in revenue (5% of sales) potentially earlier than 2030.
- Full-year EPS guidance was raised at the low end, with expectations of margin expansion assuming no economic improvement.
Management priorities
- Add substantial new projects to the ultra-high-purity plant backlog within the year.
- Grow the commercial space propellant business toward the 5% of sales target.
- Maintain disciplined capital allocation with $1.3B annual capex split between base spend and project backlog.
- Continue shareholder returns via dividend growth (raised 7%) and $800M share repurchases.
- Pursue additional bolt-on acquisitions, especially in the Americas.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-28T12:11:48.792804+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-28T12:11:48.789961+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.